Comparison of high and low dose of cyclophosphamide in lupus nephritis patients: A long-term randomized controlled trial

Comparison of high and low dose of cyclophosphamide in lupus nephritis patients: A long-term randomized controlled trial

To evaluate the outcome of low doses of cyclophosphamide (Cyclo) therapy in lupus nephritis (LN) patients, we studied 117 biopsy-proven, de novo LN WHO class IV patients double-blinded and randomized in December 1997 to receive Cyclo in different doses; Group I (n=73) received Cyclo 10 mg/kg monthly...

Full description

Bibliographic Details
Main Authors: Ahmed H Mitwalli, Jamal S Al Wakeel, Sameer Hurraib, Abu Aisha, Abdulkaraem Al Suwaida, Awatif Alam, Durdana Hammad, Fathia Sulimani, Nawaz A Memon, Akram Askar, Ali Al Tuwaijri, Abdo Qudsi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2011;volume=22;issue=5;spage=935;epage=940;aulast=Mitwalli

Internet

http://www.sjkdt.org/article.asp?issn=1319-2442;year=2011;volume=22;issue=5;spage=935;epage=940;aulast=Mitwalli

Similar Items